Your browser doesn't support javascript.
loading
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study.
Kim, Kyung-Soo; Han, Kyung Ah; Kim, Tae Nyun; Park, Cheol-Young; Park, Jung Hwan; Kim, Sang Yong; Kim, Yong Hyun; Song, Kee Ho; Kang, Eun Seok; Kim, Chul Sik; Koh, Gwanpyo; Kang, Jun Goo; Kim, Mi Kyung; Han, Ji Min; Kim, Nan Hee; Mok, Ji Oh; Lee, Jae Hyuk; Lim, Soo; Kim, Sang Soo; Kim, Tae Ho; Won, Kyu Chang; Lee, Ki Young; Cho, Jae Hyoung; Han, Ju Young; Kim, So Hun; Nah, Jae Jin; Song, Hwa Rang; Lee, Si Eun; Kim, Sungrae.
Affiliation
  • Kim KS; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
  • Han KA; Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, Republic of Korea.
  • Kim TN; Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
  • Park CY; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Park JH; Department of Internal Medicine, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Republic of Korea.
  • Kim SY; Department of Internal Medicine, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Republic of Korea.
  • Kim YH; Department of Internal Medicine, BunDang JeSaeng general Hospital, Seongnam, Republic of Korea.
  • Song KH; Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea.
  • Kang ES; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim CS; Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.
  • Koh G; Department of Internal Medicine, Jeju National University College of Medicine, Jeju, Republic of Korea.
  • Kang JG; Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Republic of Korea.
  • Kim MK; Department of Internal Medicine, Keimyung University School of Medicine, Dongsan hospital, Daegu, Republic of Korea.
  • Han JM; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
  • Kim NH; Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Mok JO; Department of Internal Medicine, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
  • Lee JH; Department of Internal Medicine, Myongji Hospital, Goyang, Republic of Korea.
  • Lim S; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Kim SS; Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
  • Kim TH; Department of Internal Medicine, Seoul Medical Center, Seoul, Republic of Korea.
  • Won KC; Department of Internal Medicine, Yeungnam University College of Medicine, Deagu, Republic of Korea.
  • Lee KY; Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea.
  • Cho JH; Department of Internal Medicine, The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Republic of Korea.
  • Han JY; Department of Internal Medicine, Central Hospital, Siheung, Republic of Korea.
  • Kim SH; Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea.
  • Nah JJ; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, Republic of Korea.
  • Song HR; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, Republic of Korea.
  • Lee SE; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, Republic of Korea.
  • Kim S; Division of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea. Electronic address: kimsunrae@catholic.ac.kr.
Diabetes Metab ; 49(4): 101440, 2023 07.
Article de En | MEDLINE | ID: mdl-36906135
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Inhibiteurs du cotransporteur sodium-glucose de type 2 / Metformine Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: Diabetes Metab Sujet du journal: ENDOCRINOLOGIA / METABOLISMO Année: 2023 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Inhibiteurs du cotransporteur sodium-glucose de type 2 / Metformine Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: Diabetes Metab Sujet du journal: ENDOCRINOLOGIA / METABOLISMO Année: 2023 Type de document: Article